New Hampshire Bill: SB 557

BILL SUMMARY

NH SB 557 restricts synthetic and semisynthetic kratom—preserving natural leaf kratom access. This aligns with the Secretary Kennedy-led FDA (July 2025), which applauds the distinction between natural leaf and synthetic derivatives. SB 557 protects consumers by scheduling concentrated alkaloid products while maintaining access to traditional kratom. This evidence-based approach targets dangerous synthetics without eliminating consumer choice for natural botanical products.

WHY IT MATTERS TO MAHA

MAHA supports SB 557 because it reflects responsible regulation endorsed by both federal health officials and consumer protection advocates. The bill respects adult medical autonomy while protecting public health by restricting only synthetically engineered products. Natural kratom leaf (which has known benefits) remains available to informed adults seeking alternatives. SB 557 demonstrates that effective public health policy distinguishes between harmful synthetics and traditional botanicals—allowing consumer choice without compromising safety. Advocates should be vigilant to ensure that future legislation does not exploit this bill to push for a blanket ban.